Use of biosimilars in inflammatory bowel diseases: A survey among the clinicians members of the Italian Group for the Study of Inflammatory Bowel Disease (IGIBD)

Affiliations

• ¹ Gastroenterology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy. Electronic address: angelo.viscido@univaq.it.
• ² Gastroenterology Unit, Department of Gastrointestinal Oncological Surgery, S. Maria del Prato Hospital, Feltre, Italy.
• ³ Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy; Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano, Italy.
• ⁴ Gastroenterology Unit, Azienda Policlinico-Università Bari, Italy.
• ⁵ Division of Gastroenterology, Ospedale Ordine Mauriziano di Torino, Turin, Italy.
• ⁶ IBD Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.